These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 19154101)

  • 21. Developmental toxicity testing for safety assessment: new approaches and technologies.
    Knudsen TB; Kavlock RJ; Daston GP; Stedman D; Hixon M; Kim JH
    Birth Defects Res B Dev Reprod Toxicol; 2011 Oct; 92(5):413-20. PubMed ID: 21770025
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relative parameter sensitivity in prenatal toxicity studies with substances classified as developmental toxicants.
    Rorije E; van Hienen FJ; Dang ZC; Hakkert BH; Vermeire T; Piersma AH
    Reprod Toxicol; 2012 Sep; 34(2):284-90. PubMed ID: 22652463
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A strategy for safety assessment of chemicals with data gaps for developmental and/or reproductive toxicity.
    Blackburn K; Daston G; Fisher J; Lester C; Naciff JM; Rufer ES; Stuard SB; Woeller K
    Regul Toxicol Pharmacol; 2015 Jul; 72(2):202-15. PubMed ID: 25910676
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comprehensive model for reproductive and developmental toxicity hazard identification: I. Development of a weight of evidence QSAR database.
    Matthews EJ; Kruhlak NL; Daniel Benz R; Contrera JF
    Regul Toxicol Pharmacol; 2007 Mar; 47(2):115-35. PubMed ID: 17207562
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Feasibility of human trials to assess developmental immunotoxicity, and some comparison with data on New World monkeys.
    Neubert RT; Webb JR; Neubert D
    Hum Exp Toxicol; 2002; 21(9-10):543-67. PubMed ID: 12458914
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Embryo-fetal developmental toxicity study design for pharmaceuticals.
    Wise LD; Buschmann J; Feuston MH; Fisher JE; Hew KW; Hoberman AM; Lerman SA; Ooshima Y; Stump DG
    Birth Defects Res B Dev Reprod Toxicol; 2009 Dec; 86(6):418-28. PubMed ID: 20025038
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The potential of AOP networks for reproductive and developmental toxicity assay development.
    Knapen D; Vergauwen L; Villeneuve DL; Ankley GT
    Reprod Toxicol; 2015 Aug; 56():52-5. PubMed ID: 25889759
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interpretation of skeletal variations for human risk assessment: delayed ossification and wavy ribs.
    Carney EW; Kimmel CA
    Birth Defects Res B Dev Reprod Toxicol; 2007 Dec; 80(6):473-96. PubMed ID: 18157903
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Introduction to special issue on developmental and reproductive toxicity study designs for pharmaceuticals.
    Wise LD
    Birth Defects Res B Dev Reprod Toxicol; 2009 Dec; 86(6):417. PubMed ID: 20025037
    [No Abstract]   [Full Text] [Related]  

  • 30. Testing strategies for embryo-fetal toxicity of human pharmaceuticals. Animal models vs. in vitro approaches: a workshop report.
    van der Laan JW; Chapin RE; Haenen B; Jacobs AC; Piersma A
    Regul Toxicol Pharmacol; 2012 Jun; 63(1):115-23. PubMed ID: 22449444
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The way forward in reproductive/developmental toxicity testing.
    Spielmann H
    Altern Lab Anim; 2009 Dec; 37(6):641-56. PubMed ID: 20105000
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Using zebrafish in systems toxicology for developmental toxicity testing.
    Nishimura Y; Inoue A; Sasagawa S; Koiwa J; Kawaguchi K; Kawase R; Maruyama T; Kim S; Tanaka T
    Congenit Anom (Kyoto); 2016 Jan; 56(1):18-27. PubMed ID: 26537640
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Developmental and reproductive toxicity testing of vaccines.
    Barrow P
    J Pharmacol Toxicol Methods; 2012 Mar; 65(2):58-63. PubMed ID: 22233769
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Applying a weight of evidence approach to the evaluation of developmental toxicity of biopharmaceuticals.
    Rocca M; Morford LL; Blanset DL; Halpern WG; Cavagnaro J; Bowman CJ
    Regul Toxicol Pharmacol; 2018 Oct; 98():69-79. PubMed ID: 30009863
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exposure assessments in reproductive and developmental toxicity testing: An IQ-DruSafe industry survey on current practices and experiences in support of exposure-based high dose selection.
    Andrews PA; McNerney ME; DeGeorge JJ
    Regul Toxicol Pharmacol; 2019 Oct; 107():104413. PubMed ID: 31229519
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Altered axial skeletal development.
    Tyl RW; Chernoff N; Rogers JM
    Birth Defects Res B Dev Reprod Toxicol; 2007 Dec; 80(6):451-72. PubMed ID: 18157900
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prenatal developmental toxicity of decabromodiphenyl ethane in the rat and rabbit.
    Hardy ML; Mercieca MD; Rodwell DE; Stedeford T
    Birth Defects Res B Dev Reprod Toxicol; 2010 Apr; 89(2):139-46. PubMed ID: 20437473
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reproduction and development.
    Spielmann H
    Environ Health Perspect; 1998 Apr; 106 Suppl 2(Suppl 2):571-6. PubMed ID: 9599704
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The era of 3Rs implementation in developmental and reproductive toxicity (DART) testing: Current overview and future perspectives.
    Beekhuijzen M
    Reprod Toxicol; 2017 Sep; 72():86-96. PubMed ID: 28552675
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.